Xenglu Met 5/500mg Tablet

Xenglu Met 5/500mg Tablet – Gentle Starter Empagliflozin + Metformin XR

  • Empagliflozin 5mg + Metformin XR 500mg combo
  • Gentle dual therapy with full heart & kidney protection
In stock
9 People are viewing this right now
Sale price Rs.434.00 PKR
Add to Wishlist

Xenglu Met 5/500mg Tablet

Xenglu Met 5/500mg Tablet – Gentle Starter Empagliflozin + Metformin XR

Rs.434.00

Xenglu Met 5/500mg Tablet – Mild Dual Therapy with Heart & Kidney Protection from Day One

Xenglu Met 5/500mg Tablet combines empagliflozin 5mg (SGLT2 inhibitor) with metformin extended-release 500mg in a single, easy-to-tolerate once-daily tablet. This gentle-strength combination is perfect for patients newly starting dual therapy or those sensitive to higher metformin doses delivers steady blood sugar reduction while adding clinically proven cardiovascular protection, slows diabetic kidney disease progression, and offers modest weight loss and blood pressure lowering. The low-dose, extended-release formula minimizes stomach upset, making it an excellent first-step combination for long-term diabetes management

  • Gentle starter dose with excellent stomach tolerance
  • Steady 24-hour glucose control from extended-release metformin
  • Proven heart failure & kidney disease protection
  • Promotes gentle weight loss & lowers blood pressure
  • Simple once-daily tablet

  1. Take one tablet once daily with your evening meal to reduce stomach discomfort
  2. Swallow whole with water – do not crush, chew or split
  3. Take at the same time every day
  4. Continue healthy diet, exercise and regular glucose monitoring
  5. If you miss a dose, take it as soon as remembered unless it’s almost time for the next one

Q1: Is this strength good for beginners?
A1: Yes – the 500mg extended-release metformin + 5mg empagliflozin is gentle and ideal when starting combination therapy.

Q2: Will I still lose weight with only 5mg empagliflozin?
A2: Yes, most patients lose 1–3 kg due to calorie loss in urine.

Q3: How much does it lower A1C?
A3: Typically 1.0–1.6% reduction, with excellent tolerability.

Q4: Do I get heart and kidney protection at this low dose?
A4: Absolutely – empagliflozin’s cardio-renal benefits are proven even at 5mg and 10mg doses.

Q5: Is it easier on the stomach than regular metformin?
A5: Yes – extended-release 500mg causes far fewer GI side effects.

Empagliflozin, Metformin Hydrochloride (Extended-Release), Microcrystalline Cellulose, Hypromellose, Crospovidone, Magnesium Stearate, Titanium Dioxide, Macrogol, Iron Oxide Yellow

  • Use only under doctor supervision with regular kidney function and blood monitoring
  • Drink plenty of fluids to reduce risk of dehydration or urinary infections
  • Stop immediately if lactic acidosis symptoms appear (unusual muscle pain, breathing difficulty, extreme tiredness)
  • Not for type 1 diabetes or diabetic ketoacidosis
  • Avoid in severe kidney impairment (eGFR <30) or severe liver disease
  • Discontinue before major surgery or contrast scans

Recently viewed products